Cytarabine Injection, Solution
Product Images NDC 25021-223

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cytarabine (NDC 25021-223). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sagent Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Cyt00 0002 01)

Structural Formula (Cyt00 0002 01)
Chemical structure diagram of cytarabine showing molecular formula C9H13N3O5 and molecular weight 243.22.*
FDA Label Image

Figure (Cyt00 0002 02)

Figure (Cyt00 0002 02)
Label for Cytarabine Injection 2 grams per 20 mL (100 mg/mL) by Sagent Pharmaceuticals. The label states it is a 20 mL single-dose vial for intravenous, intrathecal, and subcutaneous use. It includes storage instructions, a caution for cytotoxic agent handling, barcodes, and manufacturer information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.